Pharma’s R&D, commercial approach shifts amid global policy evolution

Neutral

AI Analysis

Summary

A survey of 175 pharma executives reveals a shift in industry approach, with increasing reluctance to launch products in lower-value markets and heightened focus on real-world evidence (RWE) amid evolving global policy.

Importance:2/10

Sentiment:

-0.20

industry_trendsR&D_strategymarket_accessreal_world_evidencepolicy

Related Companies

$GBCYD

Read the original article

Published by Pharmaceutical Technology on September 9, 2026 3:36 PM

Read Original